Current concepts in managing central serous chorioretinopathy.
نویسندگان
چکیده
Central serous chorioretinopathy (CSC) affects roughly 10 men and two women per 100,000 people, and they are often younger, working-aged individuals with high visual demands. Randomized clinical trials in CSC are scarce and typically evaluate dozens of patients1-12 (Table, page 11) rather than the hundreds or even thousands of patients evaluated in trials for age-related macular degeneration (AMD), retinal vein occlusion, and diabetic retinopathy. Unfortunately, to date there are no FDAapproved medications for CSC, leaving ophthalmologists without a large treatment armamentarium.
منابع مشابه
Central serous chorioretinopathy treated with topical dorzolamide: A case series study
Abstract The aim of this study was to investigate the improvements of central serous chorioretinopathy (CSC) treated with topical dorzolamide. These observational case studies included nine eyes of the nine patients with CSC, treated by a physician with topical dorzolamide consecutively over a one-month period. The central macular thickness and best-corrected visual acuity (BCVA) were measured...
متن کاملCentral serous chorioretinopathy and glucocorticoids.
Central serous chorioretinopathy is a relatively common retinal disease characterized by the accumulation of subretinal fluid at the posterior pole of the fundus, creating a circumscribed area of serous retinal detachment. It typically affects young and middle-aged men with no previous medical and family history, and no systemic symptoms or signs. However, it has been noted that central serous ...
متن کاملCentral Serous Chorioretinopathy Address for correspondence: Vasan Eye Care, Kochi
Central serous chorioretinopathy (CSC) was first described by von Graefe in 1866, who named it as ‘relapsing central luetic retinitis’.[1] A variety of names have since been used to describe this idiopathic detachment of the neurosensory retina.[2] It was more than 100 years later that Maumenee, using fluorescein angioscopy, noted that the detachment of the macula resulted from a leak at the le...
متن کاملPhotodynamic Therapy and Central Serous Chorioretinopathy
Central serous chorioretinopathy is a common acquired maculopathy. Multiple studies showed that photodynamic therapy is useful treatment for acute and chronic central serous chorioretinopathy. The exact mechanism of photodynamic therapy in treating central serous chorioretinopathy is not clear, but it is thought to be caused by short-term choriocapillaris hypoperfusion and long-term choroidal v...
متن کاملCentral serous chorioretinopathy.
BACKGROUND Central serous chorioretinopathy is a condition typically affecting young adults between 25 and 50 years of age. It is predominating in type A personality trait men. Central serous chorioretinopathy is defined clinically as a detachment of the sensory retina that is commonly unilateral but can also be bilateral. Laser photocoagulation has been used widely with central serous choriore...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Ophthalmic surgery, lasers & imaging retina
دوره 45 1 شماره
صفحات -
تاریخ انتشار 2014